Influenza Vaccine Market (Type: Inactivated and Live Attenuated; Valency: Quadrivalent and Trivalent; Age Group: Pediatric and Adult) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
Report Highlights
Influenza Vaccine Market – Scope of Report
TMR’s report on the global influenza vaccine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global influenza vaccine market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global influenza vaccine market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the influenza vaccine market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global influenza vaccine market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global influenza vaccine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global influenza vaccine market.
The report delves into the competitive landscape of the global influenza vaccine market. Key players operating in the global influenza vaccine market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global influenza vaccine market profiled in this report.
Key Questions Answered in Global Influenza Vaccine Market Report
- What is the sales/revenue generated by influenza vaccine across all regions during the forecast period?
- What are the opportunities in the global influenza vaccine market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2023 |
| Forecast period considered | 2023-2031 |
| Units considered | $ Million |
| Segments covered | By Type, By Age Group, By Valency, By Distribution Channel, By Region |
| Industry covered | Healthcare |
| Countries covered | North America, Latin America, Europe, Asia Pacific, Middle East & Africa |
| Companies studied |
|
Influenza Vaccine Market – Research Objectives and Research Approach
The comprehensive report on the global influenza vaccine market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global influenza vaccine market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global influenza vaccine market.
- Table 1 : Global Influenza Vaccine Market Value (US$ Mn) Forecast, by Type, 2017–2031
- Table 2 : Global Influenza Vaccine Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
- Table 3 : Global Influenza Vaccine Market Value (US$ Mn) Forecast, by Valency, 2017–2031
- Table 4 : Global Influenza Vaccine Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 5 : Global Influenza Vaccine Market Value (US$ Mn) Forecast, by Region, 2017–2031
- Table 6 : North America Influenza Vaccine Market Value (US$ Mn) Forecast, by Country, 2017–2031
- Table 7 : North America Influenza Vaccine Market Value (US$ Mn) Forecast, by Type, 2017–2031
- Table 8 : North America Influenza Vaccine Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
- Table 9 : North America Influenza Vaccine Market Value (US$ Mn) Forecast, by Valency, 2017–2031
- Table 10 : North America Influenza Vaccine Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 11 : Europe Influenza Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 12 : Europe Influenza Vaccine Market Value (US$ Mn) Forecast, by Type, 2017–2031
- Table 13 : Europe Influenza Vaccine Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
- Table 14 : Europe Influenza Vaccine Market Value (US$ Mn) Forecast, by Valency, 2017–2031
- Table 15 : Europe Influenza Vaccine Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 16 : Asia Pacific Influenza Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 17 : Asia Pacific Influenza Vaccine Market Value (US$ Mn) Forecast, by Type, 2017–2031
- Table 18 : Asia Pacific Influenza Vaccine Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
- Table 19 : Asia Pacific Influenza Vaccine Market Value (US$ Mn) Forecast, by Valency, 2017–2031
- Table 20 : Asia Pacific Influenza Vaccine Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 21 : Latin America Influenza Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 22 : Latin America Influenza Vaccine Market Value (US$ Mn) Forecast, by Type, 2017–2031
- Table 23 : Latin America Influenza Vaccine Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
- Table 24 : Latin America Influenza Vaccine Market Value (US$ Mn) Forecast, by Valency, 2017–2031
- Table 25 : Latin America Influenza Vaccine Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Table 26 : Middle East & Africa Influenza Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 27 : Middle East & Africa Influenza Vaccine Market Value (US$ Mn) Forecast, by Type, 2017–2031
- Table 28 : Middle East & Africa Influenza Vaccine Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
- Table 29 : Middle East & Africa Influenza Vaccine Market Value (US$ Mn) Forecast, by Valency, 2017–2031
- Table 30 : Middle East & Africa Influenza Vaccine Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
- Figure 1 : Global Influenza Vaccine Market Value (US$ Mn) Forecast, 2017–2031
- Figure 2 : Global Influenza Vaccine Market Value Share, by Type (2022)
- Figure 3 : Global Influenza Vaccine Market Value Share, by Valency (2022)
- Figure 4 : Global Influenza Vaccine Market Value Share, by Age Group (2022)
- Figure 5 : Global Influenza Vaccine Market Value Share, by Distribution Channel (2022)
- Figure 6 : Global Influenza Vaccine Market Value Share, by Region (2022)
- Figure 7 : Global Influenza Vaccine Market Value Share Analysis, by Type, 2022 and 2031
- Figure 8 : Global Influenza Vaccine Market Attractiveness Analysis, by Type, 2023–2031
- Figure 9 : Global Influenza Vaccine Market Value Share Analysis, by Age Group, 2022 and 2031
- Figure 10 : Global Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2023–2031
- Figure 11 : Global Influenza Vaccine Market Value Share Analysis, by Valency, 2022 and 2031
- Figure 12 : Global Influenza Vaccine Market Attractiveness Analysis, by Valency, 2023–2031
- Figure 13 : Global Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
- Figure 14 : Global Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023–2031
- Figure 15 : Global Influenza Vaccine Market Value Share Analysis, by Region, 2022 and 2031
- Figure 16 : Global Influenza Vaccine Market Attractiveness Analysis, by Region, 2022-2031
- Figure 17 : North America Influenza Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
- Figure 18 : North America Influenza Vaccine Market Value Share Analysis, by Country, 2022 and 2031
- Figure 19 : North America Influenza Vaccine Market Attractiveness Analysis, by Country, 2023–2031
- Figure 20 : North America Influenza Vaccine Market Value Share Analysis, by Type, 2022 and 2031
- Figure 21 : North America Influenza Vaccine Market Attractiveness Analysis, by Type, 2023–2031
- Figure 22 : North America Influenza Vaccine Market Value Share Analysis, by Age Group, 2022 and 2031
- Figure 23 : North America Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2023–2031
- Figure 24 : North America Influenza Vaccine Market Value Share Analysis, by Valency, 2022 and 2031
- Figure 25 : North America Influenza Vaccine Market Attractiveness Analysis, by Valency, 2023–2031
- Figure 26 : North America Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
- Figure 27 : North America Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023–2031
- Figure 28 : Europe Influenza Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
- Figure 29 : Europe Influenza Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 30 : Europe Influenza Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
- Figure 31 : Europe Influenza Vaccine Market Value Share Analysis, by Type, 2022 and 2031
- Figure 32 : Europe Influenza Vaccine Market Attractiveness Analysis, by Type, 2023–2031
- Figure 33 : Europe Influenza Vaccine Market Value Share Analysis, by Age Group, 2022 and 2031
- Figure 34 : Europe Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2023–2031
- Figure 35 : Europe Influenza Vaccine Market Value Share Analysis, by Valency, 2022 and 2031
- Figure 36 : Europe Influenza Vaccine Market Attractiveness Analysis, by Valency, 2023–2031
- Figure 37 : Europe Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
- Figure 38 : Europe Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023–2031
- Figure 39 : Asia Pacific Influenza Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
- Figure 40 : Asia Pacific Influenza Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 41 : Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
- Figure 42 : Asia Pacific Influenza Vaccine Market Value Share Analysis, by Type, 2022 and 2031
- Figure 43 : Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Type, 2023–2031
- Figure 44 : Asia Pacific Influenza Vaccine Market Value Share Analysis, by Age Group, 2022 and 2031
- Figure 45 : Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2023–2031
- Figure 46 : Asia Pacific Influenza Vaccine Market Value Share Analysis, by Valency, 2022 and 2031
- Figure 47 : Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Valency, 2023–2031
- Figure 48 : Asia Pacific Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
- Figure 49 : Asia Pacific Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023–2031
- Figure 50 : Latin America Influenza Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
- Figure 51 : Latin America Influenza Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 52 : Latin America Influenza Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
- Figure 53 : Latin America Influenza Vaccine Market Value Share Analysis, by Type, 2022 and 2031
- Figure 54 : Latin America Influenza Vaccine Market Attractiveness Analysis, by Type, 2023–2031
- Figure 55 : Latin America Influenza Vaccine Market Value Share Analysis, by Age Group, 2022 and 2031
- Figure 56 : Latin America Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2023–2031
- Figure 57 : Latin America Influenza Vaccine Market Value Share Analysis, by Valency, 2022 and 2031
- Figure 58 : Latin America Influenza Vaccine Market Attractiveness Analysis, by Valency, 2023–2031
- Figure 59 : Latin America Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
- Figure 60 : Latin America Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023–2031
- Figure 61 : Middle East & Africa Influenza Vaccine Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
- Figure 62 : Middle East & Africa Influenza Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
- Figure 63 : Middle East & Africa Influenza Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
- Figure 64 : Middle East & Africa Influenza Vaccine Market Value Share Analysis, by Type, 2022 and 2031
- Figure 65 : Middle East & Africa Influenza Vaccine Market Attractiveness Analysis, by Type, 2023–2031
- Figure 66 : Middle East & Africa Influenza Vaccine Market Value Share Analysis, by Age Group, 2022 and 2031
- Figure 67 : Middle East & Africa Influenza Vaccine Market Attractiveness Analysis, by Age Group, 2023–2031
- Figure 68 : Middle East & Africa Influenza Vaccine Market Value Share Analysis, by Valency, 2022 and 2031
- Figure 69 : Middle East & Africa Influenza Vaccine Market Attractiveness Analysis, by Valency, 2023–2031
- Figure 70 : Middle East & Africa Influenza Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031
- Figure 71 : Middle East & Africa Influenza Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023–2031
- Figure 72 : Global Influenza Vaccine Market Share Analysis, by Company, 2022
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.